ID
25651
Description
Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Concomitant medications
Mots-clés
Versions (4)
- 11/08/2017 11/08/2017 -
- 18/08/2017 18/08/2017 -
- 18/08/2017 18/08/2017 -
- 08/09/2017 08/09/2017 -
Téléchargé le
8 septembre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Concomitant medications GSK study Dyskinesia in Parkinson's disease NCT00363727
Concomitant medications GSK study Dyskinesia in Parkinson's disease NCT00363727
Description
Concomitant medications
Description
If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Type de données
boolean
Alias
- UMLS CUI [1]
- C2347852
Description
(Trade Name preferred)
Type de données
text
Alias
- UMLS CUI [1]
- C0013227
Description
Total daily dose
Type de données
float
Alias
- UMLS CUI [1]
- C2348070
Description
The following lists of abbreviations are examples which can be used to aid the completion of the appropriate items on the L-Dopa page.These are not all inclusive lists and are for guidance only, other abbreviations may be used if necessary. Abbreviation Label: TAB = Tablet, MCL = Microlitre, ML = Millilitre, L = Litre, MCG = Microgram, MG = Milligram, G = Gram
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0450442
- UMLS CUI [1,2]
- C1519795
Description
The following lists of abbreviations are examples which can be used to aid the completion of the appropriate items on the L-Dopa page.These are not all inclusive lists and are for guidance only, other abbreviations may be used if necessary. Abbreviation Label: IM = Intramuscular, IH = Inhalation, IV = Intravenous, NS = Nasal, TP = Topical, PO = Oral, VG = Vaginal
Type de données
integer
Alias
- UMLS CUI [1]
- C0013153
Description
Reason for Medication
Type de données
integer
Alias
- UMLS CUI [1]
- C2826696
Description
Start Date
Type de données
date
Alias
- UMLS CUI [1]
- C0808070
Description
Stop Date
Type de données
date
Alias
- UMLS CUI [1]
- C0806020
Description
Ongoing Medication
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant medications GSK study Dyskinesia in Parkinson's disease NCT00363727
C0678257 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,2])